Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Persistent Cervical Cancer”

136 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 136 results

Large-scale testing (Phase 3)Study completedNCT03556839
What this trial is testing

Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab in Metastatic Carcinoma of the Cervix

Who this might be right for
Carcinoma of the Cervix, Stage IVB
Grupo Español de Investigación en Cáncer de Ovario 410
Testing effectiveness (Phase 2)Study completedNCT01266447
What this trial is testing

Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Small Cell Carcinoma+5 more
National Cancer Institute (NCI) 27
Testing effectiveness (Phase 2)Study completedNCT04188847
What this trial is testing

First-line Chemotherapy for Recurrent Cervical Cancer

Who this might be right for
Recurrent Cervical CarcinomaPersistent Advanced Cervical CarcinomaChemotherapy+3 more
Lei Li 37
Large-scale testing (Phase 3)WithdrawnNCT00057928
What this trial is testing

S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
SWOG Cancer Research Network
Large-scale testing (Phase 3)Study completedNCT00003945
What this trial is testing

Comparison of Three Chemotherapy Regimens in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer

Who this might be right for
Cervical Cancer
Gynecologic Oncology Group 400
Testing effectiveness (Phase 2)Ended earlyNCT00138151
What this trial is testing

Isotretinoin, Interferon Alpha-2b, and Paclitaxel in Stage IV, Recurrent, or Persistent Cervical Cancer

Who this might be right for
Cervical Cancer
University of Medicine and Dentistry of New Jersey 33
Testing effectiveness (Phase 2)Ended earlyNCT03108495
What this trial is testing

Study of LN-145, Autologous Tumor Infiltrating Lymphocytes in the Treatment of Patients With Cervical Carcinoma

Who this might be right for
Cervical Carcinoma
Iovance Biotherapeutics, Inc. 210
Not applicableStudy completedNCT01647425
What this trial is testing

Alcohol and Tobacco Consumption in Patients With Head and Neck or Lung Cancer

Who this might be right for
Head and Neck CancerLung Cancer
Centre Oscar Lambret 385
Testing effectiveness (Phase 2)Study completedNCT00309959
What this trial is testing

ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Small Cell Carcinoma+2 more
Gynecologic Oncology Group 37
Testing effectiveness (Phase 2)UnknownNCT04395612
What this trial is testing

Niraparib Combined With Brivanib or Toripalimab in Patients With Cervical Cancer

Who this might be right for
Cervical Cancer
Chongqing University Cancer Hospital 38
Testing effectiveness (Phase 2)Study completedNCT00041093
What this trial is testing

Docetaxel in Treating Patients With Persistent or Recurrent Cervical Cancer

Who this might be right for
Cervical Squamous Cell Carcinoma, Not Otherwise SpecifiedRecurrent Cervical Carcinoma
Gynecologic Oncology Group 27
Early research (Phase 1)Study completedNCT04430842
What this trial is testing

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Who this might be right for
AstrocytomaBrain CancerBrain Metastases+20 more
Quadriga Biosciences, Inc. 15
Testing effectiveness (Phase 2)Study completedNCT00026260
What this trial is testing

SU5416 in Treating Patients With Persistent or Recurrent Cervical Cancer

Who this might be right for
Cervical Cancer
Gynecologic Oncology Group
Large-scale testing (Phase 3)Active Not RecruitingNCT04982237
What this trial is testing

AK104 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Akeso 445
Testing effectiveness (Phase 2)Ended earlyNCT03367871
What this trial is testing

Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer

Who this might be right for
Cervical Cancer
University of Miami 17
Large-scale testing (Phase 3)Looking for participantsNCT06459687
What this trial is testing

Phase III Study of Socazolimab as First-Line Treatment in Persistent, Recurrent, or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Lee's Pharmaceutical Limited 440
Testing effectiveness (Phase 2)UnknownNCT05310331
What this trial is testing

Donafenib for Recurrent Cervical Cancer

Who this might be right for
Targeted TherapyChemotherapyRecurrent Cervical Carcinoma+4 more
Lei Li 20
Not applicableEnded earlyNCT00669422
What this trial is testing

ChemoFx® PRO - A Post-Market Data Collection Study

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer+5 more
Precision Therapeutics 2,756
Large-scale testing (Phase 3)Study completedNCT00064077
What this trial is testing

Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma+2 more
Gynecologic Oncology Group 513
Testing effectiveness (Phase 2)Study completedNCT00100789
What this trial is testing

S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
SWOG Cancer Research Network 67
Next Page